TAZOCIN FOR INJECTION 4.5 g/vial
Product details
Registration number: SIN08362P
Classification: Prescription Only
Active ingredients:
- PIPERACILLIN SODIUM 4170 mg EQV PIPERACILLIN
- TAZOBACTAM SODIUM 536.6 mg/vial EQV TAZOBACTAM
Strength:
- 4000 mg/vial
- 500 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: PFIZER PRIVATE LIMITED
ATC code: J01CR05
HSA approval date: 3 October 1995
Manufacturer(s):
- Wyeth Lederle S.r.l
- Shandong Anxin Pharmaceutical Co.,Ltd.
Manufacturing country/countries: ITALY; CHINA
What are the HSA registration number and classification for TAZOCIN FOR INJECTION 4.5 g/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN08362P
Classification: Prescription Only
What active ingredients and strength are recorded for TAZOCIN FOR INJECTION 4.5 g/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- PIPERACILLIN SODIUM 4170 mg EQV PIPERACILLIN
- TAZOBACTAM SODIUM 536.6 mg/vial EQV TAZOBACTAM
Strength:
- 4000 mg/vial
- 500 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TAZOCIN FOR INJECTION 4.5 g/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for TAZOCIN FOR INJECTION 4.5 g/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for TAZOCIN FOR INJECTION 4.5 g/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Wyeth Lederle S.r.l
- Shandong Anxin Pharmaceutical Co.,Ltd.
Manufacturing country/countries: ITALY; CHINA
Where can I look up TAZOCIN FOR INJECTION 4.5 g/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN08362P or the exact product name TAZOCIN FOR INJECTION 4.5 g/vial. The general register link does not preselect this product.
What are the source dates for this TAZOCIN FOR INJECTION 4.5 g/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TAZOCIN FOR INJECTION 4.5 g/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN08362P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)